In due compliance with the provisions of the Companies Act, 2013 read with Rules made thereunder Oxygenta Pharmaceutical Limited ('the Company') circulated a Notice dated 03rd September 2022 ('AGM Notice') to all its shareholders for convening the AGM as mentioned above.
Certain inadvertent errors have been noticed in the Explanatory Statement annexed with the AGM Notice in respect of the special resolution (Item. no. 7,8 & 9 of the AGM Notice). Accordingly, vide this Addendum, we wish to inform our shareholders the explanatory statement part of the AGM Notice shall be read as under. Other contents of the AGM Notice remain unchanged.
This addendum shall form an integral part of AGM Notice and shall also be available at Corporate Announcement Section of the Company's website http://oxygentapharma.com/, on the website of and on the website of the Stock Exchanges i.e. BSE Limited at www.bseindia.com.
This is for your information and records.